With high competitive players in the international arena, exporting the product was indeed a challenge for ORCHEV. Though the product has been made suitable to access every market and fulfil all the requirements of foreign associates, still there existed a need to gain a competitive edge in developing the export market. At present ORCHEV is exporting 60 to 70% of its final output to International markets.
Orchev Pharma is using it’s R&D to contribute towards the health of people around the world with superior products, manufactured in state-of-art facility under strict WHO-GMP/CEP/Others (check Regulatory Approval page) compliance.
We are currently exporting products to more than 55 countries world-wide, covering 5 continents. Major markets currently served by us are below:
- Asia
- Europe
- Latam
- Middle East
- North Africa
Orchev is combining its strengths to ensure sustainable growth and realize our long-term strategic vision of developing Orchev a specialized pharmaceutical company with a global presence
